A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61P 21/00 (2006.01)
Patent
CA 2508691
Trauma to the spinal cord initiates an inflammatory response that results in secondary injury to the surrounding tissue, thereby exacerbating the effects of the initial injury. These secondary injury effects are contributed to, in part, by the activation of complement and the associated inflammatory reaction at the site of injury. The present invention describes a method for treating and/or ameliorating these secondary effects and improving locomotor function of a vertebrate that has suffered a spinal cord injury by administering a complement inhibitory protein to the individual as soon as possible after the initial injury occurs. According to this method, by inhibiting the activation of complement, inflammation and the resulting secondary tissue injury are reduced, thereby improving the prognosis of a patient suffering a spinal cord injury.
Fan Guang-Yu
Li Liang-Man
Zhu Yue
Avant Immunotherapeutics Inc.
Celldex Therapeutics Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Use of complement inhibitory proteins to treat spinal cord... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of complement inhibitory proteins to treat spinal cord..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of complement inhibitory proteins to treat spinal cord... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1898195